Orchid Biosciences Seeks to Change Name to Orchid Cellmark | GenomeWeb

NEW YORK, April 14 (GenomeWeb News) - Orchid Biosciences is seeking stockholder approval to change its name to Orchid Cellmark to reflect the company's positioning as a provider of DNA identity testing services, the firm said yesterday.

Shareholders will consider the name change at the Princeton, NJ-based company's annual stockholders meeting on June 8.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.